Biotage Ab Stock Cash Flow From Operations
| BITGF Stock | USD 14.63 1.60 12.28% |
Biotage AB fundamentals help investors to digest information that contributes to Biotage AB's financial success or failures. It also enables traders to predict the movement of Biotage OTC Stock. The fundamental analysis module provides a way to measure Biotage AB's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biotage AB otc stock.
Biotage |
Biotage AB OTC Stock Cash Flow From Operations Analysis
Biotage AB's Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current Biotage AB Cash Flow From Operations | 353 M |
Most of Biotage AB's fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biotage AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
| Competition |
In accordance with the recently published financial statements, Biotage AB has 353 M in Cash Flow From Operations. This is 33.05% lower than that of the sector and 33.07% higher than that of the Cash Flow From Operations industry. The cash flow from operations for all United States stocks is 63.65% higher than that of the company.
Biotage Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biotage AB's direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Biotage AB could also be used in its relative valuation, which is a method of valuing Biotage AB by comparing valuation metrics of similar companies.Biotage AB is currently under evaluation in cash flow from operations category among related companies.
Biotage Fundamentals
| Return On Equity | 0.18 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.16 % | |||
| Current Valuation | 1.17 B | |||
| Shares Outstanding | 65.98 M | |||
| Shares Owned By Insiders | 0.58 % | |||
| Shares Owned By Institutions | 64.57 % | |||
| Price To Earning | 47.58 X | |||
| Price To Book | 6.36 X | |||
| Price To Sales | 6.61 X | |||
| Revenue | 1.23 B | |||
| Gross Profit | 755 M | |||
| EBITDA | 347 M | |||
| Net Income | 205 M | |||
| Cash And Equivalents | 15.1 M | |||
| Cash Per Share | 0.23 X | |||
| Total Debt | 150 M | |||
| Debt To Equity | 0.16 % | |||
| Current Ratio | 2.43 X | |||
| Book Value Per Share | 1.17 X | |||
| Cash Flow From Operations | 353 M | |||
| Earnings Per Share | 0.35 X | |||
| Number Of Employees | 510 | |||
| Beta | 0.81 | |||
| Market Capitalization | 1.12 B | |||
| Total Asset | 1.99 B | |||
| Retained Earnings | 541 M | |||
| Working Capital | 212 M | |||
| Current Asset | 327 M | |||
| Current Liabilities | 115 M | |||
| Z Score | 4.2 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 1.99 B |
About Biotage AB Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biotage AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotage AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotage AB based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Biotage AB
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biotage AB position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotage AB will appreciate offsetting losses from the drop in the long position's value.Moving together with Biotage OTC Stock
| 0.66 | GOOG | Alphabet Class C | PairCorr |
| 0.65 | AMZN | Amazon Inc | PairCorr |
Moving against Biotage OTC Stock
| 0.65 | JNJ | Johnson Johnson Financial Report 18th of July 2024 | PairCorr |
| 0.6 | AAPL | Apple Inc Financial Report 1st of August 2024 | PairCorr |
| 0.46 | MSB | Mesabi Trust | PairCorr |
| 0.44 | PFE | Pfizer Inc Report 7th of May 2024 | PairCorr |
The ability to find closely correlated positions to Biotage AB could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biotage AB when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biotage AB - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biotage AB to buy it.
The correlation of Biotage AB is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biotage AB moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biotage AB moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biotage AB can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotage AB. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Biotage AB information on this page should be used as a complementary analysis to other Biotage AB's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Complementary Tools for Biotage OTC Stock analysis
When running Biotage AB's price analysis, check to measure Biotage AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotage AB is operating at the current time. Most of Biotage AB's value examination focuses on studying past and present price action to predict the probability of Biotage AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotage AB's price. Additionally, you may evaluate how the addition of Biotage AB to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stocks Directory Find actively traded stocks across global markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |